Open original FDA record ↗Recall record
- FDA identifier
- Z-2299-2020
- Company in FDA record
- INARI MEDICAL
- FDA record creation date
- Jun 9, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The hemostasis valve of aspiration guide catheter devices may fail to seal resulting in a loss of vacuum during thrombus aspiration, which may result the procedure being prolonged as another device must be used or suboptimal thrombus removal if the problem is not detected.
Source facts
- Action
- On 03/23/20, Urgent Medical Device Recall notices were emailed to customers. Customers were asked to take the following actions: 1.Immediately review your inventory for the affected devices and quarantined to prevent their use. 2.Complete and return the Customer Response Form. 3.Return quarantined devices to recalling firm. 4.Report any adverse health consequences experienced with the use of this product to the recalling firm. Customers with additional questions were encouraged to contact the firm at: 877.923.4747 or customerservice@inarimedical.com Additional recall notices with an expanded scope, dated 03/26/20, were also sent to additional customers.
- Initiated
- 2020-03-23
- Root cause
- Equipment maintenance
- Terminated
- 2021-08-13
- Distribution
- U.S Distribution in the states of .: IA, GA, MO, MI, AZ, FL, NJ, MN, LA, PA, AL, OH, NY, WI, CA, TX, TN, NH, IL, NC, CT, CO, OK, OR, IN, MA, VA, KY, WA, MS, SC, UT, SD, ND, AR, ID, DE, including DC.
- Recall number
- Z-2299-2020
- Recall status
- Terminated
- CDRH record ID
- 180814
- FDA record created
- 2020-06-09
- Recall event number
- 85424